The Studies

While there is hope that the worst of the pandemic is behind us, hundreds of thousands of new cases of COVID-19 are still reported daily around the globe. That is why it's so important to continue to advance not only prevention, but also treatment of COVID-19. These clinical trials are evaluating whether an oral study drug reduces the duration and/or severity of illness among people with COVID-19 or prevents the onset of COVID-19 symptoms in household members.

Pediatric Recently Diagnosed at Risk

COVID-19 — Recently Diagnosed Or Symptomatic Children And Teens At Increased Risk Of Severe Illness From COVID-19

For children and teens who have COVID-19 symptoms or have recently tested positive for COVID-19, and have health conditions that put them at risk for severe illness. Now enrolling.

immuno

COVID-19 — RECENTLY DIAGNOSED, SYMPTOMATIC PEOPLE WHO ARE IMMUNOCOMPROMISED

For people 12 years of age or older who recently tested positive for COVID-19, currently have at least 1 sign/symptom, and have health conditions that put them at risk for severe illness. Click to learn more, or call us at 800-887-7002. Now enrolling.

Pregnant Women Recently Diagnosed

PREGNANT WOMEN WITH RECENTLY DIAGNOSED, SYMPTOMATIC COVID-19

A COVID-19 clinical research study is underway to compare the pharmacokinetics (how a drug is absorbed, distributed, and processed in the body) and tolerability of PAXLOVID™ in pregnant versus non-pregnant women ages 18 to 50 with mild-to-moderate symptomatic COVID-19. Now enrolling.

Recently Diagnosed At Risk

COVID-19 — RECENTLY DIAGNOSED PATIENTS AT INCREASED RISK OF WORSENING SYMPTOMS

For those 18 years of age and older who have COVID-19 symptoms, as well as health conditions that put them at high risk for severe illness. No longer enrolling.

Household Members of Recently Diagnosed

COVID-19 — FOR HOUSEHOLD MEMBERS OF THOSE RECENTLY DIAGNOSED

For adults living in the same home as individuals with diagnosed, symptomatic COVID-19. No longer enrolling.

Recently Diagosed Patients

COVID-19 — RECENTLY DIAGNOSED PATIENTS

For those 18 years of age and older who have COVID-19 symptoms and have tested positive for COVID-19 within the last 5 days, but do not have any health conditions putting them at risk for severe illness, or have these conditions but are fully vaccinated. No Longer Enrolling.

An Important Contribution

While there is hope that the worst of the pandemic is behind us, hundreds of thousands of new cases of COVID-19 are still reported daily around the globe. That is why it's so important to continue to advance not only prevention, but also treatment of COVID-19.

If you or a household member has recently been diagnosed with COVID-19, participation in one of these studies can be an option to consider not only for yourself, but as an important contribution to the global effort to move beyond COVID-19.

Joining a clinical trial is an important and personal decision. We hope it is one you will consider.

Be Represented

While everyone needs to be represented in vaccine clinical trials, it is especially important that these vaccine trials include people from the communities most significantly impacted by COVID-19. By choosing to volunteer, you will represent people like you - in age, gender, race, ethnicity, and from communities like yours. Involving people from all backgrounds will improve the development of this investigational vaccine for everyone. By volunteering for a COVID-19 vaccine study, you can make a difference.

 

why participate